Cargando…

Strongyloidiasis and Infective Dermatitis Alter Human T Lymphotropic Virus-1 Clonality in vivo

Human T-lymphotropic Virus-1 (HTLV-1) is a retrovirus that persists lifelong by driving clonal proliferation of infected T-cells. HTLV-1 causes a neuroinflammatory disease and adult T-cell leukemia/lymphoma. Strongyloidiasis, a gastrointestinal infection by the helminth Strongyloides stercoralis, an...

Descripción completa

Detalles Bibliográficos
Autores principales: Gillet, Nicolas A., Cook, Lucy, Laydon, Daniel J., Hlela, Carol, Verdonck, Kristien, Alvarez, Carolina, Gotuzzo, Eduardo, Clark, Daniel, Farré, Lourdes, Bittencourt, Achiléa, Asquith, Becca, Taylor, Graham P., Bangham, Charles R. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3617147/
https://www.ncbi.nlm.nih.gov/pubmed/23592987
http://dx.doi.org/10.1371/journal.ppat.1003263
_version_ 1782265225381150720
author Gillet, Nicolas A.
Cook, Lucy
Laydon, Daniel J.
Hlela, Carol
Verdonck, Kristien
Alvarez, Carolina
Gotuzzo, Eduardo
Clark, Daniel
Farré, Lourdes
Bittencourt, Achiléa
Asquith, Becca
Taylor, Graham P.
Bangham, Charles R. M.
author_facet Gillet, Nicolas A.
Cook, Lucy
Laydon, Daniel J.
Hlela, Carol
Verdonck, Kristien
Alvarez, Carolina
Gotuzzo, Eduardo
Clark, Daniel
Farré, Lourdes
Bittencourt, Achiléa
Asquith, Becca
Taylor, Graham P.
Bangham, Charles R. M.
author_sort Gillet, Nicolas A.
collection PubMed
description Human T-lymphotropic Virus-1 (HTLV-1) is a retrovirus that persists lifelong by driving clonal proliferation of infected T-cells. HTLV-1 causes a neuroinflammatory disease and adult T-cell leukemia/lymphoma. Strongyloidiasis, a gastrointestinal infection by the helminth Strongyloides stercoralis, and Infective Dermatitis associated with HTLV-1 (IDH), appear to be risk factors for the development of HTLV-1 related diseases. We used high-throughput sequencing to map and quantify the insertion sites of the provirus in order to monitor the clonality of the HTLV-1-infected T-cell population (i.e. the number of distinct clones and abundance of each clone). A newly developed biodiversity estimator called “DivE” was used to estimate the total number of clones in the blood. We found that the major determinant of proviral load in all subjects without leukemia/lymphoma was the total number of HTLV-1-infected clones. Nevertheless, the significantly higher proviral load in patients with strongyloidiasis or IDH was due to an increase in the mean clone abundance, not to an increase in the number of infected clones. These patients appear to be less capable of restricting clone abundance than those with HTLV-1 alone. In patients co-infected with Strongyloides there was an increased degree of oligoclonal expansion and a higher rate of turnover (i.e. appearance and disappearance) of HTLV-1-infected clones. In Strongyloides co-infected patients and those with IDH, proliferation of the most abundant HTLV-1(+) T-cell clones is independent of the genomic environment of the provirus, in sharp contrast to patients with HTLV-1 infection alone. This implies that new selection forces are driving oligoclonal proliferation in Strongyloides co-infection and IDH. We conclude that strongyloidiasis and IDH increase the risk of development of HTLV-1-associated diseases by increasing the rate of infection of new clones and the abundance of existing HTLV-1(+) clones.
format Online
Article
Text
id pubmed-3617147
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-36171472013-04-16 Strongyloidiasis and Infective Dermatitis Alter Human T Lymphotropic Virus-1 Clonality in vivo Gillet, Nicolas A. Cook, Lucy Laydon, Daniel J. Hlela, Carol Verdonck, Kristien Alvarez, Carolina Gotuzzo, Eduardo Clark, Daniel Farré, Lourdes Bittencourt, Achiléa Asquith, Becca Taylor, Graham P. Bangham, Charles R. M. PLoS Pathog Research Article Human T-lymphotropic Virus-1 (HTLV-1) is a retrovirus that persists lifelong by driving clonal proliferation of infected T-cells. HTLV-1 causes a neuroinflammatory disease and adult T-cell leukemia/lymphoma. Strongyloidiasis, a gastrointestinal infection by the helminth Strongyloides stercoralis, and Infective Dermatitis associated with HTLV-1 (IDH), appear to be risk factors for the development of HTLV-1 related diseases. We used high-throughput sequencing to map and quantify the insertion sites of the provirus in order to monitor the clonality of the HTLV-1-infected T-cell population (i.e. the number of distinct clones and abundance of each clone). A newly developed biodiversity estimator called “DivE” was used to estimate the total number of clones in the blood. We found that the major determinant of proviral load in all subjects without leukemia/lymphoma was the total number of HTLV-1-infected clones. Nevertheless, the significantly higher proviral load in patients with strongyloidiasis or IDH was due to an increase in the mean clone abundance, not to an increase in the number of infected clones. These patients appear to be less capable of restricting clone abundance than those with HTLV-1 alone. In patients co-infected with Strongyloides there was an increased degree of oligoclonal expansion and a higher rate of turnover (i.e. appearance and disappearance) of HTLV-1-infected clones. In Strongyloides co-infected patients and those with IDH, proliferation of the most abundant HTLV-1(+) T-cell clones is independent of the genomic environment of the provirus, in sharp contrast to patients with HTLV-1 infection alone. This implies that new selection forces are driving oligoclonal proliferation in Strongyloides co-infection and IDH. We conclude that strongyloidiasis and IDH increase the risk of development of HTLV-1-associated diseases by increasing the rate of infection of new clones and the abundance of existing HTLV-1(+) clones. Public Library of Science 2013-04-04 /pmc/articles/PMC3617147/ /pubmed/23592987 http://dx.doi.org/10.1371/journal.ppat.1003263 Text en © 2013 Gillet et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Gillet, Nicolas A.
Cook, Lucy
Laydon, Daniel J.
Hlela, Carol
Verdonck, Kristien
Alvarez, Carolina
Gotuzzo, Eduardo
Clark, Daniel
Farré, Lourdes
Bittencourt, Achiléa
Asquith, Becca
Taylor, Graham P.
Bangham, Charles R. M.
Strongyloidiasis and Infective Dermatitis Alter Human T Lymphotropic Virus-1 Clonality in vivo
title Strongyloidiasis and Infective Dermatitis Alter Human T Lymphotropic Virus-1 Clonality in vivo
title_full Strongyloidiasis and Infective Dermatitis Alter Human T Lymphotropic Virus-1 Clonality in vivo
title_fullStr Strongyloidiasis and Infective Dermatitis Alter Human T Lymphotropic Virus-1 Clonality in vivo
title_full_unstemmed Strongyloidiasis and Infective Dermatitis Alter Human T Lymphotropic Virus-1 Clonality in vivo
title_short Strongyloidiasis and Infective Dermatitis Alter Human T Lymphotropic Virus-1 Clonality in vivo
title_sort strongyloidiasis and infective dermatitis alter human t lymphotropic virus-1 clonality in vivo
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3617147/
https://www.ncbi.nlm.nih.gov/pubmed/23592987
http://dx.doi.org/10.1371/journal.ppat.1003263
work_keys_str_mv AT gilletnicolasa strongyloidiasisandinfectivedermatitisalterhumantlymphotropicvirus1clonalityinvivo
AT cooklucy strongyloidiasisandinfectivedermatitisalterhumantlymphotropicvirus1clonalityinvivo
AT laydondanielj strongyloidiasisandinfectivedermatitisalterhumantlymphotropicvirus1clonalityinvivo
AT hlelacarol strongyloidiasisandinfectivedermatitisalterhumantlymphotropicvirus1clonalityinvivo
AT verdonckkristien strongyloidiasisandinfectivedermatitisalterhumantlymphotropicvirus1clonalityinvivo
AT alvarezcarolina strongyloidiasisandinfectivedermatitisalterhumantlymphotropicvirus1clonalityinvivo
AT gotuzzoeduardo strongyloidiasisandinfectivedermatitisalterhumantlymphotropicvirus1clonalityinvivo
AT clarkdaniel strongyloidiasisandinfectivedermatitisalterhumantlymphotropicvirus1clonalityinvivo
AT farrelourdes strongyloidiasisandinfectivedermatitisalterhumantlymphotropicvirus1clonalityinvivo
AT bittencourtachilea strongyloidiasisandinfectivedermatitisalterhumantlymphotropicvirus1clonalityinvivo
AT asquithbecca strongyloidiasisandinfectivedermatitisalterhumantlymphotropicvirus1clonalityinvivo
AT taylorgrahamp strongyloidiasisandinfectivedermatitisalterhumantlymphotropicvirus1clonalityinvivo
AT banghamcharlesrm strongyloidiasisandinfectivedermatitisalterhumantlymphotropicvirus1clonalityinvivo